A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

Shares of Exact Sciences Corp. (EXAS) traded over 2% higher on Tuesday afternoon after the company launched a new test ...

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Advice on how to manage a patient with ongoing intermittent diarrhoea after a positive FIT but negative colonoscopy ...

The findings published Monday analyzed data from 2001 through 2022. However, incidence rates among women have been rising. Separately, a survey shows women are reluctant to have cancer screening ...

A cancer drug from partners AstraZeneca ... Sankyo are not disclosing specific details from the Phase 3 test in metastatic HER2-positive breast yet. But the companies said Monday that the planned ...

A spit test for prostate cancer could be better at detecting the disease than present methods such as blood tests, a study ...

HER2-positive metastatic breast cancer is an aggressive disease driven by overexpression or amplification of HER2, affecting 15-20% of patients with metastatic breast cancer. While HER2-targeted ...